Eastman Board Declares Dividend

Eastman Board Declares Dividend

KINGSPORT, Tenn.–(BUSINESS WIRE)–
The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.79 per share on the company’s common stock.

The dividend is payable Oct. 6, 2023, to stockholders of record as of Sept. 15, 2023.

Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company’s innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive and diverse company, Eastman employs approximately 14,500 people around the world and serves customers in more than 100 countries. The company had 2022 revenue of approximately $10.6 billion and is headquartered in Kingsport, Tennessee, USA. For more information, visit www.eastman.com.

Media: Tracy Kilgore Addington

423-224-0498 / [email protected]

Investors: Greg Riddle

212-835-1620 / [email protected]

KEYWORDS: United States North America Tennessee

INDUSTRY KEYWORDS: Packaging Chemicals/Plastics Manufacturing

MEDIA:

Logo
Logo

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Verizon Communications Inc. (VZ)

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Pennsylvania on behalf of all persons or entities who purchased the securities of Verizon Communications Inc. (“Verizon” or the “Company”) (NYSE: VZ) between February 4, 2020 and July 26, 2023, both dates inclusive (the “Class Period”).

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Verizon owns cables around the country that are highly toxic due to their being wrapped in lead, and which harm Company employees and non-employees alike; (2) it faces potentially significant litigation risk, regulatory risk, and reputational harm as a result of its ownership of these lead-covered cables and the health risks stemming from their presence around the United States; (3) it was warned about the damage and risks presented by these cables but did not disclose them as a potential threat to employee safety or to everyday people and communities; and (4) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On July 9, 2023, The Wall Street Journal released an article titled “America is Wrapped in Miles of Toxic Lead Cables” which detailed how “[t]elecom companies laid them (toxic lead cables) decades ago and thousands were left behind, posing a hidden health hazard today.” The article further detailed how Verizon and other telecommunications companies “have known about the lead-covered cables and the potential risks of exposure to their workers” and that “lead was potentially leaching into the environment.” On this news, the price of Verizon stock declined.

Then, on July 14, 2023, The Wall Street Journal published an article titled “‘I was Really Sick, and I Didn’t Know From What,’” which detailed, among other things, health problems suffered by current and former Verizon employees as a result of their exposure to objects covered in lead. On this news, the price of Verizon stock further declined.

Thereafter, on July 17, 2023, The Wall Street Journal published articles titled “Environmental Groups Ask EPA to Shield Public From Abandoned Lead Cables” and “Telecom Stocks Extend Losses After WSJ Toxic Lead Investigation” that further detailed the fallout from The Wall Street Journal’s July 9 article, including how Verizon and other telecommunications companies had come under scrutiny from the U.S. Environmental Protection Agency and U.S. Federal Communications Commission. On this news, the price of Verizon stock declined more than 7%.

Finally, on July 26, 2023, The Wall Street Journal published an article titled “Justice Department and EPA Probe Telecom Companies Over Lead Cables” that detailed further regulatory scrutiny focused on Verizon and other telecommunications companies, including from federal agencies as well as state and local governments. On this news, the price of Verizon stock declined, further damaging investors.

Investors who purchased or otherwise acquired shares of Verizon should contact the Firm prior to the October 2, 2023 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.



Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes

SAN DIEGO–(BUSINESS WIRE)–
Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services (HHS), to develop a Flu A/B, RSV, and COVID-19 molecular multiplex test for both over-the-counter (OTC) and point-of-care (POC) use. Cue’s test would detect and differentiate between influenza A, influenza B, respiratory syncytial virus (RSV), and COVID-19 simultaneously, with results delivered in approximately 25 minutes to connected smart devices.

The company has also applied with the U.S. FDA for Emergency Use Authorization (EUA) for its Cue Flu + COVID-19 Molecular Test for at-home and point-of-care (POC) use. Cue also requested De Novo classification from the FDA for the Cue RSV Molecular Test for at-home and point-of-care use. In March, the company received an EUA from the FDA for the Cue Mpox (Monkeypox) Molecular Test, which can be performed at the point-of-care at any CLIA-waived facility.

Influenza, RSV, and COVID-19 are common respiratory viruses that can be serious, especially for older adults, those with weakened immune systems, and infants. Combined, these viruses are responsible for hundreds of thousands of hospitalizations each year. RSV is the leading cause of hospitalization among children less than one year of age in the U.S. The flu alone caused between 27 million and 54 million illnesses last respiratory season (2022-2023), according to the Centers for Disease Control and Prevention (CDC). And approximately 7,000 people are still admitted to the hospital per week due to COVID-19 in the U.S, per CDC data as of July 15, 2023.

“By expanding our successful partnership with BARDA, we’re able to meet a critical health need by utilizing Cue’s diagnostic platform to detect and differentiate between some of the most common respiratory viruses that have similar symptoms but distinct treatment options,” said Ayub Khattak, Chairman and CEO of Cue Health. “We expect this test will arm individuals and their providers with actionable information that can reduce community spread, increase the efficacy of treatment, and help lead to better health outcomes. We’re honored to be called upon once again to partner with BARDA to strengthen the nation’s emergency preparedness, and in doing so, empower more people to live their healthiest lives.”

Cue was awarded a contract by BARDA in 2020 to accelerate the development, validation, and FDA clearance of its COVID-19 test, which was the first molecular test to receive FDA Emergency Use Authorization for at-home and over-the-counter use without a prescription. Cue also recently received De Novo authorization from the FDA for the same COVID-19 test (Cue COVID-19 Molecular Test), which was the first De Novo granted for any home use respiratory test available without a prescription. Cue’s work with BARDA began in 2018 when the company received base funding to accelerate the development and regulatory validation of over-the-counter and professional use flu test cartridges, the Cue Health Monitoring System, and cartridge manufacturing technology.

The Cue molecular tests all run on the Cue Health Monitoring System (Reader), which has an installed base of more than a quarter million. Cue’s molecular tests are manufactured at its San Diego headquarters, where production and assembly lines have the built-in capability to pivot between manufacturing different Cue diagnostic tests in near real-time.

This project is being funded in whole or in part with federal funds from the Department of Health and Human Services; Administration of Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50123C00036.

About Cue Health

Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cue’s customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 test, which became the first home use respiratory test to receive this FDA approval. Cue also received Emergency Use Authorization from the FDA for its molecular mpox test at the point-of-care. To further expand its test menu, Cue has made other submissions that are now under review by the FDA, including for the Cue® Flu + COVID-19 Molecular Test and the Cue® RSV Molecular Test, both of which are designed for at-home and point-of-care use. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, including those regarding Cue’s diagnostic platform, its partnership with BARDA, and statements made by Cue’s CEO, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements”. The words, without limitation, “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including those related to the expected future diagnostic test menu and the factors discussed in the “Risk Factors” section of Cue’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 16, 2023 and Cue’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed with the SEC on May 10, 2023. Any forward-looking statements contained in this press release are based on the current expectations of Cue’s management team and speak only as of the date hereof, and Cue specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

The Cue Mpox (Monkeypox) Molecular Test has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA. This product has been authorized only for the detection of nucleic acid from monkeypox virus, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

MEDIA INQUIRIES

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Medical Supplies Biotechnology Other Health Health General Health Pharmaceutical Health Technology Research Infectious Diseases Science COVID-19

MEDIA:

Logo
Logo

voxeljet AG Schedules Second Quarter 2023 Financial Results Release and Conference Call

voxeljet AG Schedules Second Quarter 2023 Financial Results Release and Conference Call

FRIEDBERG, Germany–(BUSINESS WIRE)–
voxeljet AG (NASDAQ: VJET) (the “Company” or “voxeljet”), a leading OEM and provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced that it will release its financial results for the second quarter 2023 after the closing of the financial markets on Thursday, August 17th.

The Company will host a conference call and webcast to review the results for the quarter on Friday, August 18th, 2023 at 8:30 a.m. Eastern Time. Participants from voxeljet will include its Chief Executive Officer, Dr. Ingo Ederer, and its Chief Financial Officer, Rudolf Franz, who will provide a general business update and respond to investor questions.

Interested parties may access the live audio broadcast by dialing 1-877-704-4453 in the United States/Canada, or 1-201-389-0920 for international, Conference Title “voxeljet AG Second Quarter 2023 Financial Results Conference Call”. Investors are requested to access the call at least five minutes before the scheduled start time in order to complete a brief registration. An audio replay will be available approximately two hours after the completion of the call at 1-844-512-2921 or 1-412-317-6671, Replay Conference ID number 13739752. The recording will be available for replay through August 25th, 2023.

A live webcast of the call will also be available on the investor relations section of the Company’s website. Please go to the website https://events.q4inc.com/attendee/568860706 at least fifteen minutes prior to the start of the call to register, download and install any necessary audio software. A replay will also be available as a webcast on the investor relations section of the Company’s website.

About voxeljet

voxeljet’s (NASDAQ: VJET) roots reach back to the year 1995 with the first successful dosing of UV-resins. In the context of a “hidden” project, initial 3D-printing tests are performed at the Technical University Munich. Our company was founded on May 5, 1999 as a spin-off from TUM in Munich with a clear vision in mind: to establish a new manufacturing standard by developing new generative processes for the series-production of complex components using 3D printing. In the beginning, operations are launched with four employees at the TUM. Today, we are a globally acting, leading provider of high-speed, large-format 3D printers and on-demand 3D printed parts to industrial and commercial customers. Components manufactured with the help of our technology are flying in space, make mobility more efficient and the production of new engineering solutions possible. For more information, visit www.voxeljet.com.

Investors and Media

Johannes Pesch

Director, Investor Relations and Business Development

[email protected]

+49-821-7483-172

KEYWORDS: Germany Europe

INDUSTRY KEYWORDS: Electronic Design Automation Professional Services Technology Manufacturing Finance Other Manufacturing Hardware

MEDIA:

Logo
Logo

Tutor Perini Reports Second Quarter 2023 Results

Tutor Perini Reports Second Quarter 2023 Results

  • Revenue of $1.02 billion in Q2 2023, up 19% compared to $861.0 million in Q2 2022
  • Solid operating cash flow of $56.3 million in Q2 2023 compared to $58.0 million in Q2 2022; year-to-date operating cash flow of $77.7 million was the second-highest result for the first six months of any year since the merger of Tutor-Saliba Corporation and Perini Corporation in 2008
  • Backlog grew to $10.9 billion, up 27% year-over-year compared to $8.5 billion at Q2 2022; anticipating continued strong backlog growth over the next several quarters

 

LOS ANGELES–(BUSINESS WIRE)–
Tutor Perini Corporation (the “Company”) (NYSE: TPC), a leading civil, building and specialty construction company, reported results today for the second quarter of 2023. Revenue was $1.02 billion, up 19% compared to $861.0 million for the second quarter of last year. The increase was largely due to contributions from certain Civil segment mass-transit projects in California that have significant work remaining, as well as the absence of certain prior-year unfavorable adjustments. In addition, customer budgetary constraints induced by the COVID-19 pandemic, combined with certain political and other factors, resulted in the Company not being awarded certain Civil segment projects over the last few years totaling more than $10.0 billion despite having been the low or preferred bidder. Not being awarded these projects also impacted revenue for the first two quarters of both 2023 and 2022.

Income from construction operations for the second quarter of 2023 was $2.4 million, compared to loss from construction operations of $90.6 million for the same period in 2022. The improvement was largely due to strong contributions from certain mass-transit projects in California, including favorable adjustments totaling $58.1 million on one project associated with changes in estimates due to improved performance, as well as the absence of certain prior-year unfavorable adjustments that negatively impacted income (loss) from construction operations in the 2022 period by an aggregate $67.5 million. The improvement was partially offset by unfavorable non-cash adjustments of $35.8 million due to changes in estimates on the Specialty Contractors segment’s electrical and mechanical scope of a transportation project in the Northeast associated with a change in the expected recovery on certain unapproved change requests, as well as a non-cash charge of $24.7 million that resulted from an adverse legal ruling on a Specialty Contractors segment educational facilities project in New York. Net loss attributable to the Company for the second quarter of 2023 was $37.5 million, or a $0.72 diluted loss per common share, compared to a net loss of $63.0 million, or a $1.23 diluted loss per common share, for the second quarter of 2022.

The Company generated $56.3 million of cash from operating activities in the second quarter of 2023 compared to $58.0 million for the same period of 2022, driven by solid collection activities, including collections associated with certain settlement negotiations that concluded over the past few quarters. During the first six months of 2023, the Company generated $77.7 million of cash from operating activities, the second-highest result for the first six months of any year since the merger of Tutor-Saliba Corporation and Perini Corporation in 2008. The Company continues to anticipate strong operating cash generation over the remainder of 2023, with operating cash flow for 2023 still expected to exceed the record amount reported for 2022.

Backlog grew to $10.9 billion as of June 30, 2023, up 27% compared to $8.5 billion for the same period last year, and up 37% compared to backlog of $7.9 billion at the end of 2022. The Building segment was the primary contributor to the new award activity in the second quarter of 2023. The most notable new awards and contract adjustments in the second quarter of 2023 included the $3.0 billion Brooklyn Jail design-build project in New York; a $222 million military facilities project at Tinian International Airport in the Commonwealth of the Northern Mariana Islands; $206 million of additional funding for a mass-transit project in California; $103 million of additional funding for a health care project in California; $87 million of additional funding for a mass-transit project in Minnesota; and a $54 million bridge project in Minnesota.

Outlook and Guidance

“We delivered 19% revenue growth and solid operating cash flow for the second quarter of 2023. It is noteworthy that our year-to-date operating cash flow of $77.7 million was the second-highest result for the first six months of any year since the merger in 2008. We continue to anticipate that our operating cash flow for 2023 will exceed the record $207.0 million we generated last year and are confident that this should enable us to facilitate a successful refinancing by early next year,” said Ronald Tutor, Chairman and Chief Executive Officer. Tutor continued, “We also increased our backlog 27% year-over-year to $10.9 billion and believe that our strong backlog growth will continue over the next 12 to 18 months, as we bid and expect to capture our share of a tremendous pipeline of large new project opportunities, which is expected to position us favorably for strong growth and profitability in the years ahead.”

In light of the Company’s year-to-date financial results and continued uncertainties that could cause a wide range of results in the second half of 2023, the Company is not providing new guidance. There are still certain positive events that could transpire later this year, which could offset much of the negative results the Company has experienced so far in 2023. The Company anticipates a return to positive EPS performance in 2024.

Second Quarter 2023 Conference Call

The Company will host a conference call at 2:00 PM Pacific Time on Thursday, August 3, 2023, to discuss the second quarter 2023 results. To participate in the conference call, please dial 877-407-8293 five to ten minutes prior to the scheduled time. International callers should dial 1-201-689-8349.

The conference call will be webcast live over the Internet and can be accessed by all interested parties on Tutor Perini’s website at www.tutorperini.com. For those unable to participate during the live call, the webcast will be available for replay shortly after the call on the website.

About Tutor Perini Corporation

Tutor Perini Corporation is a leading civil, building and specialty construction company offering diversified general contracting and design-build services to private customers and public agencies throughout the world. We have provided construction services since 1894 and have established a strong reputation within our markets by executing large, complex projects on time and within budget, while adhering to strict quality control measures. We offer general contracting, pre-construction planning and comprehensive project management services, including planning and scheduling of manpower, equipment, materials and subcontractors required for a project. We also offer self-performed construction services including site work, concrete forming and placement, steel erection, electrical, mechanical, plumbing and heating, ventilation and air conditioning (HVAC). We are known for our major complex building project commitments, as well as our capacity to perform large and complex transportation and heavy civil construction for government agencies and private customers throughout the world.

Forward-Looking Statements

The statements contained in this release, including those set forth in the section “Outlook and Guidance,” that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including without limitation, statementsregarding the Company’s expectations, hopes, beliefs, intentions or strategies regarding the future and statements regarding future guidance or estimates and non-historical performance. These forward-looking statements are based on the Company’s current expectations and beliefs concerning future developments and their potential effects on the Company. While the Company’s expectations, beliefs and projections are expressed in good faith and the Company believes there is a reasonable basis for them, there can be no assurance that future developments affecting the Company will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the Company) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: unfavorable outcomes of existing or future litigation or dispute resolution proceedings against us or customers (project owners, developers, general contractors, etc.), subcontractors or suppliers, as well as failure to promptly recover significant working capital invested in projects subject to such matters; revisions of estimates of contract risks, revenue or costs, economic factors such as inflation, the timing of new awards, or the pace of project execution, which has resulted and may continue to result in losses or lower than anticipated profit; increased competition and failure to secure new contracts; contract requirements to perform extra work beyond the initial project scope, which has and in the future could result in disputes or claims and adversely affect our working capital, profits and cash flows; risks and other uncertainties associated with assumptions and estimates used to prepare our financial statements; a significant slowdown or decline in economic conditions, such as those presented during a recession; failure to meet contractual schedule requirements, which could result in higher costs and reduced profits or, in some cases, exposure to financial liability for liquidated damages and/or damages to customers, as well as damage to our reputation; inability to attract and retain our key officers, and to adequately plan for their succession, and hire and retain personnel required to execute and perform on our contracts; risks related to our international operations, such as uncertainty of U.S. government funding, as well as economic, political, regulatory and other risks, including risks of loss due to acts of war, labor conditions, and other unforeseeable events in countries where we do business, which could adversely affect our revenue and earnings; decreases in the level of government spending for infrastructure and other public projects; an inability to obtain bonding could have a negative impact on our operations and results; possible systems and information technology interruptions and breaches in data security and/or privacy; failure to meet our obligations under our debt agreements, especially in a high interest rate environment; downgrades in our credit ratings; failure of our joint venture partners to perform their venture obligations, which could impose additional financial and performance obligations on us, resulting in reduced profits or losses and/or reputational harm; the impact of inclement weather conditions on projects; risks related to government contracts and related procurement regulations; significant fluctuations in the market price of our common stock, which could result in substantial losses for stockholders and potentially subject us to securities litigation; client cancellations of, or reductions in scope under, contracts reported in our backlog; violations of the U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws; public health crises, such as COVID-19, have adversely impacted, and could in the future adversely impact, our business, financial condition and results of operations by, among other things, delaying the timing of project bids and/or awards and the timing of dispute resolutions and associated collections; physical and regulatory risks related to climate change; impairment of our goodwill or other indefinite-lived intangible assets; the exertion of influence over the Company by our chairman and chief executive officer due to his position and significant ownership interest; and other risks and uncertainties discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 15, 2023 and in other reports that we file with the Securities and Exchange Commission from time to time. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Tutor Perini Corporation

Condensed Consolidated Statements of Operations

Unaudited

 

 

 

 

 

 

 

 

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

(in thousands, except per common share amounts)

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

REVENUE

 

$

1,021,751

 

 

$

861,027

 

 

$

1,798,051

 

 

$

1,813,181

 

COST OF OPERATIONS

 

 

(956,790

)

 

 

(895,250

)

 

 

(1,757,259

)

 

 

(1,797,059

)

GROSS PROFIT (LOSS)

 

 

64,961

 

 

 

(34,223

)

 

 

40,792

 

 

 

16,122

 

General and administrative expenses

 

 

(62,573

)

 

 

(56,331

)

 

 

(120,349

)

 

 

(116,583

)

INCOME (LOSS) FROM CONSTRUCTION OPERATIONS

 

 

2,388

 

 

 

(90,554

)

 

 

(79,557

)

 

 

(100,461

)

Other income, net

 

 

3,058

 

 

 

1,020

 

 

 

9,475

 

 

 

4,717

 

Interest expense

 

 

(22,016

)

 

 

(16,204

)

 

 

(43,529

)

 

 

(32,696

)

LOSS BEFORE INCOME TAXES

 

 

(16,570

)

 

 

(105,738

)

 

 

(113,611

)

 

 

(128,440

)

Income tax (expense) benefit

 

 

(194

)

 

 

43,718

 

 

 

47,918

 

 

 

47,607

 

NET LOSS

 

 

(16,764

)

 

 

(62,020

)

 

 

(65,693

)

 

 

(80,833

)

LESS: NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

 

 

20,770

 

 

 

983

 

 

 

21,037

 

 

 

3,804

 

NET LOSS ATTRIBUTABLE TO TUTOR PERINI CORPORATION

 

$

(37,534

)

 

$

(63,003

)

 

$

(86,730

)

 

$

(84,637

)

BASIC LOSS PER COMMON SHARE

 

$

(0.72

)

 

$

(1.23

)

 

$

(1.68

)

 

$

(1.65

)

DILUTED LOSS PER COMMON SHARE

 

$

(0.72

)

 

$

(1.23

)

 

$

(1.68

)

 

$

(1.65

)

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING:

 

 

 

 

 

 

 

 

BASIC

 

 

51,803

 

 

 

51,276

 

 

 

51,678

 

 

 

51,192

 

DILUTED

 

 

51,803

 

 

 

51,276

 

 

 

51,678

 

 

 

51,192

 

Tutor Perini Corporation

Segment Information

Unaudited

 

 

 

 

 

 

 

 

 

Reportable Segments

 

 

 

 

(in thousands)

Civil

Building

Specialty

Contractors

Total

 

Corporate

 

Consolidated

Total

Three Months Ended June 30, 2023

 

 

 

 

 

 

 

 

Total revenue

$

555,553

 

$

321,933

 

$

136,323

 

$

1,013,809

 

 

$

 

 

$

1,013,809

 

Elimination of intersegment revenue

 

(1,430

)

 

9,409

 

 

(37

)

 

7,942

 

 

 

 

 

 

7,942

 

Revenue from external customers

$

554,123

 

$

331,342

 

$

136,286

 

$

1,021,751

 

 

$

 

 

$

1,021,751

 

Income (loss) from construction operations

$

105,407

 

$

(13,831

)

$

(69,832

)

$

21,744

(a)

 

$

(19,356

)(b)

 

$

2,388

 

Capital expenditures

$

9,643

 

$

1,458

 

$

256

 

$

11,357

 

 

$

1,470

 

 

$

12,827

 

Depreciation and amortization(c)

$

7,074

 

$

455

 

$

622

 

$

8,151

 

 

$

2,195

 

 

$

10,346

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2022

 

 

 

 

 

 

 

 

Total revenue

$

453,215

 

$

262,556

 

$

190,464

 

$

906,235

 

 

$

 

 

$

906,235

 

Elimination of intersegment revenue

 

(49,593

)

 

4,385

 

 

 

 

(45,208

)

 

 

 

 

 

(45,208

)

Revenue from external customers

$

403,622

 

$

266,941

 

$

190,464

 

$

861,027

 

 

$

 

 

$

861,027

 

Loss from construction operations

$

(9,767

)

$

(67

)

$

(66,731

)

$

(76,565

)(d)

 

$

(13,989

)(b)

 

$

(90,554

)

Capital expenditures

$

15,656

 

$

50

 

$

816

 

$

16,522

 

 

$

295

 

 

$

16,817

 

Depreciation and amortization(c)

$

15,025

 

$

390

 

$

508

 

$

15,923

 

 

$

2,360

 

 

$

18,283

 

____________________________________________________________________________________________________

(a)

 

During the three months ended June 30, 2023, the Company’s income (loss) from construction operations was impacted by favorable adjustments totaling $58.1 million ($46.1 million, or $0.89 per diluted share, after tax) resulting from changes in estimates due to improved performance on a Civil segment mass-transit project in California, $35.8 million ($26.0 million, or $0.50 per diluted share, after tax) of unfavorable non-cash adjustments due to changes in estimates on the Specialty Contractors segment’s electrical and mechanical scope of a transportation project in the Northeast associated with a change in the expected recovery on certain unapproved change orders, a non-cash charge of $24.7 million ($18.0 million, or $0.35 per diluted share, after tax) that resulted from an adverse legal ruling on a Specialty Contractors segment educational facilities project in New York and a $13.1 million ($10.2 million, or $0.20 per diluted share, after tax) unfavorable adjustment on a transportation project in the Northeast, split evenly between the Civil and Building segments, due to the settlement of certain change orders during project closeout.

(b)

 

Consists primarily of corporate general and administrative expenses.

(c)

 

Depreciation and amortization is included in income (loss) from construction operations.

(d)

 

During the three months ended June 30, 2022, the Company’s income (loss) from construction operations was adversely impacted by $33.5 million ($24.2 million, or $0.47 per diluted share, after tax) due to an unfavorable adjustment related to the unforeseen cost of project close-out issues, remediation work, extended project supervision and associated labor inefficiencies on the electrical component of a transportation project in the Northeast in the Specialty Contractors segment, a non-cash charge of $17.8 million that increased cost of operations ($12.8 million, or $0.25 per diluted share, after tax) associated with an unexpected partial reversal by an appellate court of previously awarded legal damages related to a completed electrical project in New York in the Specialty Contractors segment, and a $16.2 million unfavorable non-cash impact ($11.6 million, or $0.23 per diluted share, after tax) related to the settlement of a long-disputed, completed Civil segment project in Maryland.

Tutor Perini Corporation

Segment Information

Unaudited

 

 

 

 

 

 

 

Reportable Segments

 

 

(in thousands)

Civil

Building

Specialty

Contractors

Total

Corporate

Consolidated

Total

Six Months Ended June 30, 2023

 

 

 

 

 

 

Total revenue

$

933,777

 

$

551,224

 

$

333,071

 

$

1,818,072

 

$

 

$

1,818,072

 

Elimination of intersegment revenue

 

(29,784

)

 

9,771

 

 

(8

)

 

(20,021

)

 

 

 

(20,021

)

Revenue from external customers

$

903,993

 

$

560,995

 

$

333,063

 

$

1,798,051

 

$

 

$

1,798,051

 

Income (loss) from construction operations

$

123,419

 

$

(84,040

)

$

(82,280

)

$

(42,901

)(a)

$

(36,656

)(b)

$

(79,557

)

Capital expenditures

$

24,708

 

$

3,475

 

$

700

 

$

28,883

 

$

1,740

 

$

30,623

 

Depreciation and amortization(c)

$

14,055

 

$

912

 

$

1,241

 

$

16,208

 

$

4,546

 

$

20,754

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2022

 

 

 

 

 

 

Total revenue

$

913,957

 

$

618,534

 

$

421,328

 

$

1,953,819

 

$

 

$

1,953,819

 

Elimination of intersegment revenue

 

(119,540

)

 

(20,945

)

 

(153

)

 

(140,638

)

 

 

 

(140,638

)

Revenue from external customers

$

794,417

 

$

597,589

 

$

421,175

 

$

1,813,181

 

$

 

$

1,813,181

 

Income (loss) from construction operations

$

(10,734

)

$

9,397

 

$

(70,625

)

$

(71,962

)(d)

$

(28,499

)(b)

$

(100,461

)

Capital expenditures

$

26,831

 

$

52

 

$

1,454

 

$

28,337

 

$

508

 

$

28,845

 

Depreciation and amortization(c)

$

32,025

 

$

791

 

$

1,010

 

$

33,826

 

$

4,695

 

$

38,521

 

____________________________________________________________________________________________________

(a)

 

During the six months ended June 30, 2023, the Company’s income (loss) from construction operations was impacted by an adverse legal ruling on a completed mixed-use project in New York, which resulted in a non-cash, pre-tax charge of $83.6 million ($60.1 million, or $1.16 per diluted share, after-tax), of which $72.2 million impacted the Building segment and $11.4 million impacted the Specialty Contractors segment, $35.8 million ($26.0 million, or $0.50 per diluted share, after tax) of unfavorable non-cash adjustments due to changes in estimates on the Specialty Contractors segment’s electrical and mechanical scope of a transportation project in the Northeast associated with a change in the expected recovery on certain unapproved change orders, net favorable adjustments of $30.1 million ($23.9 million, or $0.46 per diluted share, after tax) for a Civil segment mass-transit project in California that resulted from changes in estimates due to improved performance, a non-cash charge of $24.7 million ($18.0 million, or $0.35 per diluted share, after tax) that resulted from an adverse legal ruling on a Specialty Contractors segment educational facilities project in New York, and a $13.1 million ($10.2 million, or $0.20 per diluted share, after tax) unfavorable adjustment on a transportation project in the Northeast, split evenly between the Civil and Building segments, due to the settlement of certain change orders during project closeout.

(b)

 

Consists primarily of corporate general and administrative expenses.

(c)

 

Depreciation and amortization is included in income (loss) from construction operations.

(d)

 

During the six months ended June 30, 2022, the Company’s income (loss) from construction operations was adversely impacted by $33.5 million ($24.2 million, or $0.47 per diluted share, after tax) due to an unfavorable adjustment related to the unforeseen cost of project close-out issues, remediation work, extended project supervision and associated labor inefficiencies on the electrical component of a transportation project in the Northeast in the Specialty Contractors segment, and $29.1 million ($22.9 million, or $0.45 per diluted share, after tax) on a Civil segment mass-transit project in California, which resulted from the successful negotiation of significant lower margin (and lower risk) change orders that increased the project’s overall estimated profit but reduced the project’s percentage of completion and overall margin percentage. The Company’s income (loss) from construction operations was also impacted by a non-cash charge of $25.5 million ($18.3 million, or $0.36 per diluted share, after tax) due to an adverse legal ruling on a dispute related to a Civil segment bridge project in New York, a non-cash charge of $17.8 million that increased cost of operations ($12.8 million, or $0.25 per diluted share, after tax) associated with an unexpected partial reversal by an appellate court of previously awarded legal damages related to a completed electrical project in New York in the Specialty Contractors segment, a $16.2 million unfavorable non-cash impact ($11.6 million, or $0.23 per diluted share, after tax) related to the settlement of a long-disputed, completed Civil segment project in Maryland, and a $14.6 million ($11.2 million, or $0.22 per diluted share, after tax) unfavorable adjustment split evenly between the Civil and Building segments due to changes in estimates on a transportation project in the Northeast.

Tutor Perini Corporation

Condensed Consolidated Balance Sheets

Unaudited

(in thousands, except share and per share amounts)

 

As of June 30,

2023

 

As of December 31,

2022

 

 

 

 

 

ASSETS

CURRENT ASSETS:

 

 

 

 

Cash and cash equivalents ($163,088 and $168,408 related to variable interest entities (“VIEs”))

 

$

263,545

 

 

$

259,351

 

Restricted cash

 

 

10,914

 

 

 

14,480

 

Restricted investments

 

 

97,293

 

 

 

91,556

 

Accounts receivable ($80,770 and $54,040 related to VIEs)

 

 

1,226,636

 

 

 

1,171,085

 

Retention receivable ($153,699 and $187,615 related to VIEs)

 

 

557,358

 

 

 

585,556

 

Costs and estimated earnings in excess of billings ($72,051 and $83,911 related to VIEs)

 

 

1,224,663

 

 

 

1,377,528

 

Other current assets ($30,813 and $33,340 related to VIEs)

 

 

165,760

 

 

 

179,215

 

Total current assets

 

 

3,546,169

 

 

 

3,678,771

 

PROPERTY AND EQUIPMENT (“P&E”), net of accumulated depreciation of $520,109 and $505,512 (net P&E of $31,883 and $22,133 related to VIEs)

 

 

444,615

 

 

 

435,088

 

GOODWILL

 

 

205,143

 

 

 

205,143

 

INTANGIBLE ASSETS, NET

 

 

69,424

 

 

 

70,542

 

OTHER ASSETS

 

 

203,164

 

 

 

153,256

 

TOTAL ASSETS

 

$

4,468,515

 

 

$

4,542,800

 

 

 

 

 

 

LIABILITIES AND EQUITY

CURRENT LIABILITIES:

 

 

 

 

Current maturities of long-term debt

 

$

20,634

 

 

$

70,285

 

Accounts payable ($33,178 and $36,484 related to VIEs)

 

 

487,769

 

 

 

495,345

 

Retention payable ($32,589 and $44,859 related to VIEs)

 

 

226,036

 

 

 

246,562

 

Billings in excess of costs and estimated earnings ($468,399 and $480,839 related to VIEs)

 

 

1,025,252

 

 

 

975,812

 

Accrued expenses and other current liabilities ($7,181 and $5,082 related to VIEs)

 

 

196,450

 

 

 

179,523

 

Total current liabilities

 

 

1,956,141

 

 

 

1,967,527

 

LONG-TERM DEBT, less current maturities, net of unamortized discount and debt issuance costs totaling $12,330 and $13,980

 

 

905,623

 

 

 

888,154

 

OTHER LONG-TERM LIABILITIES

 

 

238,550

 

 

 

245,135

 

TOTAL LIABILITIES

 

 

3,100,314

 

 

 

3,100,816

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

EQUITY

 

 

 

 

Stockholders’ equity:

 

 

 

 

Preferred stock – authorized 1,000,000 shares ($1 par value), none issued

 

 

 

 

 

 

Common stock – authorized 112,500,000 shares ($1 par value), issued and outstanding 51,969,840 and 51,521,336 shares

 

 

51,970

 

 

 

51,521

 

Additional paid-in capital

 

 

1,143,532

 

 

 

1,140,933

 

Retained earnings

 

 

217,571

 

 

 

304,301

 

Accumulated other comprehensive loss

 

 

(45,479

)

 

 

(47,037

)

Total stockholders’ equity

 

 

1,367,594

 

 

 

1,449,718

 

Noncontrolling interests

 

 

607

 

 

 

(7,734

)

TOTAL EQUITY

 

 

1,368,201

 

 

 

1,441,984

 

TOTAL LIABILITIES AND EQUITY

 

$

4,468,515

 

 

$

4,542,800

 

Tutor Perini Corporation

Condensed Consolidated Statements of Cash Flows

Unaudited

Six Months Ended June 30,

(in thousands)

 

2023

 

 

 

2022

 

Cash Flows from Operating Activities:

 

 

 

Net loss

$

(65,693

)

 

$

(80,833

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

Depreciation

 

19,636

 

 

 

28,344

 

Amortization of intangible assets

 

1,118

 

 

 

10,177

 

Share-based compensation expense

 

5,637

 

 

 

4,814

 

Change in debt discounts and deferred debt issuance costs

 

2,005

 

 

 

1,817

 

Deferred income taxes

 

(68,256

)

 

 

(61,145

)

Gain on sale of property and equipment

 

(5,038

)

 

 

(168

)

Changes in other components of working capital

 

188,761

 

 

 

269,104

 

Other long-term liabilities

 

(2,152

)

 

 

7,885

 

Other, net

 

1,632

 

 

 

(1,297

)

NET CASH PROVIDED BY OPERATING ACTIVITIES

 

77,650

 

 

 

178,698

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

Acquisition of property and equipment

 

(30,623

)

 

 

(28,845

)

Proceeds from sale of property and equipment

 

6,758

 

 

 

6,420

 

Investments in securities

 

(14,521

)

 

 

(10,409

)

Proceeds from maturities and sales of investments in securities

 

9,227

 

 

 

4,919

 

NET CASH USED IN INVESTING ACTIVITIES

 

(29,159

)

 

 

(27,915

)

 

 

 

Cash Flows from Financing Activities:

 

 

 

Proceeds from debt

 

537,500

 

 

 

412,357

 

Repayment of debt

 

(571,332

)

 

 

(439,236

)

Cash payments related to share-based compensation

 

(284

)

 

 

(1,009

)

Distributions paid to noncontrolling interests

 

(15,250

)

 

 

(24,500

)

Contributions from noncontrolling interests

 

2,000

 

 

 

3,961

 

Debt issuance, extinguishment and modification costs

 

(497

)

 

 

 

NET CASH USED IN FINANCING ACTIVITIES

 

(47,863

)

 

 

(48,427

)

 

 

 

Net increase in cash, cash equivalents and restricted cash

 

628

 

 

 

102,356

 

Cash, cash equivalents and restricted cash at beginning of period

 

273,831

 

 

 

211,396

 

Cash, cash equivalents and restricted cash at end of period

$

274,459

 

 

$

313,752

 

Tutor Perini Corporation

Backlog Information

Unaudited

(in millions)

 

Backlog at

March 31, 2023

 

New Awards in the

Three Months Ended

June 30, 2023(a)

 

Revenue Recognized in the

Three Months Ended

June 30, 2023

 

Backlog at

June 30, 2023

Civil

 

$

4,445.5

 

$

689.7

 

$

(554.1

)

 

$

4,581.1

Building

 

 

2,227.5

 

 

2,560.4

 

 

(331.4

)

 

 

4,456.5

Specialty Contractors

 

 

1,246.5

 

 

716.3

 

 

(136.3

)

 

 

1,826.5

Total

 

$

7,919.5

 

$

3,966.4

 

$

(1,021.8

)

 

$

10,864.1

(in millions)

 

Backlog at

December 31, 2022

 

New Awards in the

Six Months Ended

June 30, 2023(a)

 

Revenue Recognized in the

Six Months Ended

June 30, 2023

 

Backlog at

June 30, 2023

Civil

 

$

4,416.3

 

$

1,068.8

 

$

(904.0

)

 

$

4,581.1

Building

 

 

2,223.6

 

 

2,793.9

 

 

(561.0

)

 

 

4,456.5

Specialty Contractors

 

 

1,289.2

 

 

870.4

 

 

(333.1

)

 

 

1,826.5

Total

 

$

7,929.1

 

$

4,733.1

 

$

(1,798.1

)

 

$

10,864.1

____________________________________________________________________________________________________

(a)

New awards consist of the original contract price of projects added to our backlog plus or minus subsequent changes to the estimated total contract price of existing contracts.

 

Tutor Perini Corporation

Jorge Casado, 818-362-8391

Vice President, Investor Relations & Corporate Communications

www.tutorperini.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Building Systems Residential Building & Real Estate Commercial Building & Real Estate Construction & Property Urban Planning

MEDIA:

Logo
Logo

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Hayward Holdings, Inc. (HAYW)

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased the securities of Hayward Holdings, Inc. (“Hayward” or the “Company”) (NYSE: HAYW) between March 2, 2022 and July 27, 2022, both dates inclusive (the “Class Period”).

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Hayward Holdings and its management had engaged in a channel-stuffing scheme designed to artificially boost Hayward Holdings’ short-term sales and earnings; (ii) Hayward Holdings had flooded its channel partners with inventory that they did not want or need at a level that far outpaced then-existing consumer demand; (iii) Hayward Holdings’ channel partners were suffering from an inventory glut as a result of the channel-stuffing scheme that would require a massive de-stocking in the second half of 2022; (iv) Hayward Holdings’ channel-stuffing scheme had cannibalized future sales, materially impairing Hayward Holdings’ ability to sell to its customers; (v) the demand for pool equipment had slowed down, which, combined with flooding channel partners with more inventory, led to an inventory glut and the need for these channel partners to reduce inventory levels; and (vi) as a result of the above, Hayward Holdings’ projected 2022 financial results were not achievable and lacked a reasonable basis in fact.

On July 28, 2022, Hayward Holdings announced financial results for the second fiscal quarter of 2022, shocking analysts and investors by revealing that Hayward Holdings was expecting its channel partners to reduce their inventory on hand by approximately four to six weeks in the second half of 2022. As a result, Hayward Holdings reduced its 2022 guidance to reflect massive inventory reduction in the second half of the year. Notably, during an earnings call held that same day, defendant CEO Kevin Holleran admitted that the inventory bottleneck traced back to inventory decisions made “at the end of 2021” – i.e., before the Class Period. As a result, the price of Hayward Holdings common stock fell nearly 24%, damaging investors.

Investors who purchased or otherwise acquired shares of Hayward should contact the Firm prior to the October 2, 2023 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.



VALHI DECLARES QUARTERLY DIVIDEND

Dallas, Texas, Aug. 03, 2023 (GLOBE NEWSWIRE) — Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on September 21, 2023 to stockholders of record at the close of business on September 1, 2023.

Valhi, Inc. is engaged in the chemicals (TiO2), component products (security products and recreational marine components) and real estate management and development industries.

* * * * *

Investor Relations Contact

Bryan A. Hanley
Senior Vice President and Treasurer
Tel. 972-233-1700



MarketWise Declares Dividend on Common Stock

BALTIMORE, Aug. 03, 2023 (GLOBE NEWSWIRE) — MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or “the Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today announced that its Board of Directors declared a quarterly cash dividend to holders of Class A common stock of $0.01 per share. A comparable distribution of $0.01 per share has also been approved to holders of MarketWise, LLC common units. The dividend and distribution will be paid on October 26, 2023, to shareholders and unitholders of record as of September 5, 2023.

Amber Lee Mason, Chief Executive Officer of MarketWise commented, “Management and the Board are pleased to provide shareholders our second quarterly dividend. Our balance sheet and cash flow generation remain strong, allowing us to maintain adequate levels of cash for operations, investment and growth while providing a modest capital return to shareholders. We believe this dividend continues to demonstrate confidence in our operating strategy and our ability to generate sustainable cash flows. We are committed to managing the Company’s capital and cashflow in a way that rewards all stakeholders and creates long-term shareholder value.”


About MarketWise

Founded with a mission to level the playing field for self-directed investors, today MarketWise is a leading multi-brand subscription services platform providing premium financial research, software, education, and tools for investors.

With more than 20 years of operating history, MarketWise is currently comprised of 13 primary customer facing brands, offering more than 200 products to our community of free and paid subscribers. MarketWise’s products are a trusted source for high-value financial research, education, actionable investment ideas, and investment software. MarketWise is a 100% digital, direct-to-customer company offering its research across a variety of platforms including mobile, desktops, and tablets. MarketWise has a proven, agile, and scalable platform and our vision is to become the leading financial solutions platform for self-directed investors.


Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s performance and ability to generate cash flow. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including those described in the “Risk Factors” section of the Company’s most recently filed periodic reports on Forms 10-K and 10-Q. The Company assumes no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future, unless required by law.


MarketWise Investor Relations Contact

Jonathan Shanfield – MarketWise Investor Relations
Jamie Lillis – Solebury Strategic Communications

(800) 290-4113
Email: [email protected]


MarketWise Media Contact

Email: [email protected]



IFF Announces Dr. Casper Vroemen to Succeed Dr. Gregory Yep as Chief R&D and Sustainability Officer

IFF Announces Dr. Casper Vroemen to Succeed Dr. Gregory Yep as Chief R&D and Sustainability Officer

Vroemen—currently VP of R&D, Health & Biosciences— brings a track record of R&D leadership and commercial success to IFF’s Executive Leadership Team

NEW YORK–(BUSINESS WIRE)–
IFF (NYSE: IFF) today announces that Dr. Gregory Yep, Chief R&D and Sustainability Officer, has resigned effective Sept. 1 to pursue a new opportunity in his professional journey. Yep will be succeeded by Dr. Casper Vroemen—Vice President of R&D, Health & Biosciences—who has dedicated his career to the advancement and commercialization of leading-edge biotechnology. Vroemen will be based in Union Beach, New Jersey, and will become part of IFF’s Executive Leadership Team.

“Through Greg’s leadership, we have established IFF as the go-to partner for science-backed solutions for the health, fragrance, nutrition and home and personal care markets,” said Frank Clyburn, IFF CEO. “We thank Greg for his many contributions, and wish him well in his future endeavors. We have a strong successor in Casper, who will continue to advance our innovation pipeline and sustainability efforts.”

Vroemen joined the Company in 2004 as a scientist and project leader. Over the past two decades, he has assumed roles of increasing responsibility in research and development in Europe and the U.S., and has played a major role in establishing IFF as a bioscience powerhouse. During his tenure, he oversaw the company’s leading position in the protein engineering of industrial enzymes, contributed to the commercialization of multiple new technological advancements, and is a prolific inventor named on many patents.

As Chief R&D and Sustainability Officer, Vroemen will further IFF’s efforts in innovation, leading the company’s global R&D strategy, technological development, innovation pipeline and external collaborations. Vroemen holds a Master’s of Science in Molecular Life Sciences and a doctorate in Molecular Biology, both from Wageningen University in the Netherlands.

Welcome to IFF

At IFF (NYSE: IFF)—an industry leader in food, beverage, scent, health and biosciences—science and creativity meet to create essential solutions for a better world. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet.Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.

© 2023 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Media Relations:

Paula Heinkel

332.877.5339

[email protected]

Investor Relations:

Michael Bender

212.708.7263

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Food/Beverage Other Retail Retail Science Other Science

MEDIA:

Logo
Logo

Impinj to Participate in Upcoming Investor Conferences

Impinj to Participate in Upcoming Investor Conferences

SEATTLE–(BUSINESS WIRE)–
Impinj, Inc. (NASDAQ: PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced its participation in the following conferences:

  • Canaccord Genuity 43rd Annual Growth Conference on Thursday, August 10, 2023: Chris Diorio, Impinj co-founder and CEO, will participate in a fireside chat at 11:30 a.m. ET / 8:30 a.m. PT.

  • Goldman Sachs Communacopia and Technology Conference on Wednesday, September 6, 2023: Cary Baker, Impinj CFO, will participate in a fireside chat at 1:50 p.m. ET / 10:50 a.m. PT.

  • Piper Sandler Growth Frontiers Conference on Tuesday, September 12, 2023: Cary Baker, Impinj CFO, will participate in a fireside chat at 5:00 p.m. ET / 2:00 p.m. PT.

Live audio webcasts and replays of the fireside chats will be available on the Impinj website at investor.impinj.com.

About Impinj

Impinj (NASDAQ: PI) helps businesses and people analyze, optimize, and innovate by wirelessly connecting billions of everyday things — such as apparel, automobile parts, luggage, and shipments — to the Internet. The Impinj platform uses RAIN RFID to deliver timely data about these everyday things to business and consumer applications, enabling a boundless Internet of Things. www.impinj.com

Investor Relations

Andy Cobb, CFA

Vice President, Strategic Finance

+1 206-315-4470

[email protected]

Media Relations

Jill West

Vice President, Strategic Communications

+1 206-834-1110

[email protected]

KEYWORDS: Washington United States North America

INDUSTRY KEYWORDS: Data Management IOT (Internet of Things) Technology Mobile/Wireless Internet Hardware

MEDIA:

Logo
Logo